205 related articles for article (PubMed ID: 32692125)
1. Promoting Medication Adherence Among Psychiatric Patients With a History of Nonadherence: A Clinical Practice Improvement Program.
Xia XS; Poremski D; Ubana RL; Ravichandran N
J Psychiatr Pract; 2020 Jul; 26(4):284-293. PubMed ID: 32692125
[TBL] [Abstract][Full Text] [Related]
2. Increase Adherence to Psychotropic Medication Through Motivational Adherence Therapy: A Quality Improvement Project.
Hughes F; Vess J; Johnson E
Issues Ment Health Nurs; 2018 Aug; 39(8):709-713. PubMed ID: 29847199
[TBL] [Abstract][Full Text] [Related]
3. Motivational interviewing: a tool for increasing psychotropic medication adherence for youth.
Hamrin V; McGuinness TM
J Psychosoc Nurs Ment Health Serv; 2013 Jun; 51(6):15-8. PubMed ID: 23814821
[TBL] [Abstract][Full Text] [Related]
4. "When I Stop My Medication, Everything Goes Wrong": Content Analysis of Interviews with Adolescent Patients Treated with Psychotropic Medication.
Niemeyer L; Schumm L; Mechler K; Jennen-Steinmetz C; Dittmann RW; Häge A
J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):655-662. PubMed ID: 30148662
[TBL] [Abstract][Full Text] [Related]
5. A review of behavioral tailoring strategies for improving medication adherence in serious mental illness.
Kreyenbuhl J; Record EJ; Palmer-Bacon J
Dialogues Clin Neurosci; 2016 Jun; 18(2):191-201. PubMed ID: 27489459
[TBL] [Abstract][Full Text] [Related]
6. Non-adherence to Psychotropic Medication Among Adolescents - A Systematic Review of the Literature.
Häge A; Weymann L; Bliznak L; Märker V; Mechler K; Dittmann RW
Z Kinder Jugendpsychiatr Psychother; 2018 Jan; 46(1):69-78. PubMed ID: 27925499
[TBL] [Abstract][Full Text] [Related]
7. Incidence and factors associated with medication nonadherence in patients with mental illness: a cross-sectional study.
Lucca JM; Ramesh M; Parthasarathi G; Ram D
J Postgrad Med; 2015; 61(4):251-6. PubMed ID: 26440396
[TBL] [Abstract][Full Text] [Related]
8. Adherence to Psychotropic Medications and Associated Factors in Primary Health Care.
Miasso AI; Telles Filho PC; Borges TL; Pereira Júnior AD; Giacchero Vedana KG; Shasanmi R; Escobar Gimenes FR
Issues Ment Health Nurs; 2016 Oct; 37(10):775-783. PubMed ID: 27548290
[TBL] [Abstract][Full Text] [Related]
9. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines.
Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP
J Psychiatr Pract; 2010 Jan; 16(1):34-45. PubMed ID: 20098229
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist's Role in Improving Medication Adherence in Transplant Recipients With Comorbid Psychiatric Disorders.
Khorassani F; Tellier S; Tsapepas D
J Pharm Pract; 2019 Oct; 32(5):568-578. PubMed ID: 29554846
[TBL] [Abstract][Full Text] [Related]
11. The self-efficacy model of medication adherence in chronic mental illness.
McCann TV; Clark E; Lu S
J Clin Nurs; 2008 Nov; 17(11c):329-40. PubMed ID: 26327416
[TBL] [Abstract][Full Text] [Related]
12. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial.
Priebe S; Bremner SA; Lauber C; Henderson C; Burns T
Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Motivational Interviewing to Improve Psychotropic Medication Adherence in Adolescents.
Hamrin V; Iennaco JD
J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):148-159. PubMed ID: 27487472
[TBL] [Abstract][Full Text] [Related]
14. Exposure to Direct-to-Consumer Pharmaceutical Advertising and Medication Nonadherence Among Patients With Serious Mental Illness.
Green CE; Mojtabai R; Cullen BA; Spivak A; Mitchell M; Spivak S
Psychiatr Serv; 2017 Dec; 68(12):1299-1302. PubMed ID: 28945185
[TBL] [Abstract][Full Text] [Related]
15. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia.
Barkhof E; Meijer CJ; de Sonneville LM; Linszen DH; de Haan L
Schizophr Bull; 2013 Nov; 39(6):1242-51. PubMed ID: 24072808
[TBL] [Abstract][Full Text] [Related]
16. Assessment of impact of pharmacophilia and pharmacophobia on medication adherence in patients with psychiatric disorders: A cross-sectional study.
Christudas MJ; Gupta BS; Undela K; Isaac NM; Ram D; Ramesh M
Indian J Pharmacol; 2016; 48(6):701-705. PubMed ID: 28066110
[TBL] [Abstract][Full Text] [Related]
17. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore.
Loon SC; Jin J; Jin Goh M
J Glaucoma; 2015; 24(5):e36-42. PubMed ID: 24248002
[TBL] [Abstract][Full Text] [Related]
18. Methodological challenges in psychiatric treatment adherence research.
Velligan D; Sajatovic M; Valenstein M; Riley WT; Safren S; Lewis-Fernandez R; Weiden P; Ogedegbe G; Jamison J
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):74-91. PubMed ID: 20643631
[TBL] [Abstract][Full Text] [Related]
19. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
[TBL] [Abstract][Full Text] [Related]
20. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]